REG — JPMorgan EM G&I Plc — Transaction in Own Shares
For best results when printing this announcement, please click on link below: RNS Number: 4524V JPMorgan Emerg Mkts Growth & Income 18 September 2026 LONDON STOCK EXCHANGE ANNOUNCEMENT JPMORGAN EMERGING MARKETS GROWTH & INCOME PLC (the 'Company') REPURCHASE OF SHARES INTO TREASURY Legal Entity Identifier: 5493001VPQDYH1SSSR77 Today the Company repurchased into Treasury 400,000 Ordinary shares at 167.1893 pence per share. Following the transaction, the Company holds 385,254,798 Ordinary shares in Treasury. The shares in issue less the total number of Treasury shares is 938,380,452. The Company will only re-issue shares held in treasury at a premium to net asset value. 18th September 2026 For further information, please contact: Anmol Dhillon JPMorgan Funds Limited 0800 20 40 20 (or +44 1268 44 44 70) This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com (mailto:rns@lseg.com) or visit ( ). RNS may use
Story updates
30 pence per share. Following the transaction, the Company holds 39,663,017 ordinary shares in Treasury. The remaining ordinary shares in issue less the total number of shares in Treasury is 257,626,421. The above figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.
The Company will only re-issue shares held in Treasury at a premium to net asset value. 18th September 2026 For further information, please contact: Joel Clopon JPMorgan Funds Limited - Secretary 0800 20 40 20 (or +44 1268 44 44 70) This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply.
com) or visit ( ). RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy ( ). END POSQVLFFQKLBBBD